In this paper we provide the first model of drug elution from polymer-free arterial drug-eluting stents. The generalised model is capable of predicting drug release from a number of polymer-free systems including those that exhibit nanoporous, nanotubular and smooth surfaces. We derive analytical solutions which allow us to easily determine the important parameters that control drug release. Drug release profiles are provided, and we offer design recommendations so that the release profile may be tailored to achieve the desired outcome. The models presented here are not specific to drug-eluting stents and may also be applied to other biomedical implants that use nanoporous surfaces to release a drug
Drug-eluting stents (DES) have revolutionized the way that advanced coronary heart disease is now tr...
For the past few decades, various of drug-eluting stents (DES), coated with an additional layer over...
(Communicated by Mette S. Olufsen) Abstract. Implantation of drug eluting stents following percutane...
Journal articleIn this paper we provide the first model of drug elution from polymer-free arterial d...
AbstractIn this paper we provide the first model of drug elution from polymer-free arterial drug-elu...
Traditional coronary drug-eluting stents (DES) are made from metal and are coated with a permanent p...
Drug-eluting stents have been used widely to prevent restenosis of arteries following percutaneous b...
In this study, we consider a family of mathematical models to describe the elution of drug from poly...
Clinical evaluations have proven the efficacy of drug-elution stents (DES) in reduction of in-stent ...
Drug-eluting stents are cardiovascular stents able to release a medical drug after implantation. The...
Drug-eluting stents have significantly improved the treatment of coronary artery disease. They offer...
Implantation of drug eluting stents following percutaneous transluminal angioplasty has revealed a w...
A two dimensional coupled nonlinear non-Fickian model for drug release from a biodegradable drug elu...
Drug-eluting stents have revolutionised the treatment of coronary artery disease. These small medica...
Drug-eluting stents have been used widely to prevent restenosis of arteries following percutaneous b...
Drug-eluting stents (DES) have revolutionized the way that advanced coronary heart disease is now tr...
For the past few decades, various of drug-eluting stents (DES), coated with an additional layer over...
(Communicated by Mette S. Olufsen) Abstract. Implantation of drug eluting stents following percutane...
Journal articleIn this paper we provide the first model of drug elution from polymer-free arterial d...
AbstractIn this paper we provide the first model of drug elution from polymer-free arterial drug-elu...
Traditional coronary drug-eluting stents (DES) are made from metal and are coated with a permanent p...
Drug-eluting stents have been used widely to prevent restenosis of arteries following percutaneous b...
In this study, we consider a family of mathematical models to describe the elution of drug from poly...
Clinical evaluations have proven the efficacy of drug-elution stents (DES) in reduction of in-stent ...
Drug-eluting stents are cardiovascular stents able to release a medical drug after implantation. The...
Drug-eluting stents have significantly improved the treatment of coronary artery disease. They offer...
Implantation of drug eluting stents following percutaneous transluminal angioplasty has revealed a w...
A two dimensional coupled nonlinear non-Fickian model for drug release from a biodegradable drug elu...
Drug-eluting stents have revolutionised the treatment of coronary artery disease. These small medica...
Drug-eluting stents have been used widely to prevent restenosis of arteries following percutaneous b...
Drug-eluting stents (DES) have revolutionized the way that advanced coronary heart disease is now tr...
For the past few decades, various of drug-eluting stents (DES), coated with an additional layer over...
(Communicated by Mette S. Olufsen) Abstract. Implantation of drug eluting stents following percutane...